Development of a UreI Channel Inhibitor Drug as a Complement to Conventional Helicobacter pylori Eradication Therapy
Más información
Fecha de publicación: | 2017 |
Año de Inicio/Término: | 2017-2018 |
Financiamiento/Sponsor: | CORFO |
DOI: |
CORFO. 17IPPBIO-76192 |
Notas: | Helicobacter pylori is difficult to eradicate, and 50% of the world population may be chronically infected, and given its association with cancer. A 3D UreI urea proton-coupled channel structure could provide a platform for therapeutic eradication of the bacteria and inhibitors developments. |